Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan D T Barrett

Showing results (31-40 of 191) with videos related to

Pageof 20
Sort By:
Reviews in Medical Virology|July 11, 2008
The enigma of yellow fever in East AfricaBrett R Ellis, Alan D T Barrett
Vaccine|October 20, 2009
Development pathway for biodefense vaccinesAlan D T Barrett, David W C Beasley
The Lancet. Infectious Diseases|September 24, 2019
Are booster doses of yellow fever vaccine needed?Pedro F C Vasconcelos, Alan D T Barrett
Journal of Virology|November 20, 2002
Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope proteinDavid W C Beasley, Alan D T Barrett
Vaccine|July 2, 2008
International laboratory network for yellow fever vaccine-associated adverse eventsAlan D T Barrett, Matthias Niedrig, Dirk E Teuwen
Viral Immunology|May 15, 2008
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue VirusesJohn T Roehrig, Joachim Hombach, Alan D T Barrett
Vaccine|October 20, 2009
Introduction to this supplementAlan D T Barrett, Shan Lu, Gregory A Poland
Journal of Clinical Microbiology|September 15, 2004
Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flavivirusesMichael R Holbrook, Robert E Shope, Alan D T Barrett
Journal of Virology|June 20, 2008
Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virusGregory D Gromowski, Nicholas D Barrett, Alan D T Barrett
Virus Research|April 23, 2005
Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virusMonica A McArthur, Shu-Yuan Xiao, Alan D T Barrett
Pageof 20

Showing results (31-40 of 191) with videos related to

Sort By:
Pageof 20
Reviews in Medical Virology|July 11, 2008
The enigma of yellow fever in East AfricaBrett R Ellis, Alan D T Barrett
Vaccine|October 20, 2009
Development pathway for biodefense vaccinesAlan D T Barrett, David W C Beasley
The Lancet. Infectious Diseases|September 24, 2019
Are booster doses of yellow fever vaccine needed?Pedro F C Vasconcelos, Alan D T Barrett
Journal of Virology|November 20, 2002
Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope proteinDavid W C Beasley, Alan D T Barrett
Vaccine|July 2, 2008
International laboratory network for yellow fever vaccine-associated adverse eventsAlan D T Barrett, Matthias Niedrig, Dirk E Teuwen
Viral Immunology|May 15, 2008
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue VirusesJohn T Roehrig, Joachim Hombach, Alan D T Barrett
Vaccine|October 20, 2009
Introduction to this supplementAlan D T Barrett, Shan Lu, Gregory A Poland
Journal of Clinical Microbiology|September 15, 2004
Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flavivirusesMichael R Holbrook, Robert E Shope, Alan D T Barrett
Journal of Virology|June 20, 2008
Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virusGregory D Gromowski, Nicholas D Barrett, Alan D T Barrett
Virus Research|April 23, 2005
Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virusMonica A McArthur, Shu-Yuan Xiao, Alan D T Barrett
Pageof 20